Project Grant DP2EB034563
- The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...
- This $214,408 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to significantly advance the manufacturing processes used to produce implantable thin-film neural interfaces based on liquid crystal polymers (LCP). The key products and services to be delivered include: Developing a microfabrication process to produce bonded...
- This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is focused on the development of a novel mammalian cell-based nano-biological coating for implantable medical devices. The goal is to address the critical health and economic burden associated with implant-related infections by reducing or eliminating them through the use of this biocompatible and antimicrobial nano-biological coating. The $305,000...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $413,067 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Colorado State University to develop a new class of electrochemical biosensors that use engineered binding proteins. The goal is to simplify fabrication and improve performance of electrochemical sensors, which have potential for inexpensive, sensitive, and quantitative...
- This National Science Foundation (NSF) Division of Materials Research Project Grant, CFDA# 47.049 Mathematical and Physical Sciences, provides $400,000 in funding to The Trustees of the University of Pennsylvania to conduct collaborative research on developing novel hybrid metal-piezoelectric biomaterials for anti-infectious implantable medical devices. The key objective is to create advanced multifunctional biomaterial platforms that can effectively prevent biofilm formation and bacterial...
- The National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded a $450,000 Project Grant to the Texas A&M Engineering Experiment Station (Tees) to develop an injectable, grain-of-rice size glucose biosensor for continuous blood sugar monitoring. The key products or services to be provided under this 3-year grant include: Developing an injectable glucose biosensor comprised of a self-cleaning membrane and a near-infrared fluorescence...
- This $360,320 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop and test the first continuous electrochemical sensors for monitoring large protein and peptide analytes, such as insulin and cardiac markers. The project, titled "Aptamer Tagging with Redox Quenchers: A Critical Breakthrough in the Sensitivity of...
- This federal Project Grant award, valued at $248,645.00 and provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports research and development of advanced biomedical technologies to enhance the survival of subcutaneous encapsulated cell therapies. The principal investigator at The Leland Stanford Junior University will use approaches in...
- This National Science Foundation (NSF) Division of Computer and Network Systems Project Grant award totaling $839,998 to Michigan State University supports the development of a novel wireless optoelectronic implant system for closed-loop control of bi-hormone (insulin and glucagon) secretion from genetically modified islet organoids. The goal is to create an implantable, wireless, and battery-free device that can precisely regulate hormone levels to manage type 1 diabetes. The project involves...
- This federal Project Grant award of $425,226 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to establish the feasibility of engineering "trained innate immunity" using biomaterial implants. The primary objectives are to investigate the effects of scaffold pore size and degradation on innate immune response, as well as determine the aspects of the foreign body response necessary for innate immune training. The...
IMMUNOCOMPATIBLE ELECTRONIC POLYMERS AND DEVICES FOR IMPLANTABLE SENSORS AND STIMULATORS THAT RESIST FOREIGN-BODY RESPONSES - PROJECT SUMMARY IN RECENT DECADES, BIOIMPLANTS IN HUMAN BODIES HAVE BEEN MORE AND MORE ROUTINELY USED IN ALMOST EVERY BIOMEDICAL SPECIALTY, WITH THE FUNCTIONS RANGING FROM PATHOLOGICAL AND BIOLOGICAL STUDIES TO MEDICAL TREATMENTS AND RESTORATION OF BODY FUNCTIONS. AMONG ALL THE DIFFERENT TYPES OF BIOIMPLANTS, IMPLANTABLE ELECTRONIC DEVICES COMPRISE A MAJOR CATEGORY THAT PROVIDE HIGHLY ACCURATE AND PROGRAMMED SIGNAL TRANSDUCTIONS. HOWEVER, THE LONGEVITY AND STABILITY OF ALL TYPES OF BIOIMPLANTS, INCLUDING ELECTRONIC DEVICES, HAVE BEEN FACING A COMMON CHALLENGE, THAT IS THE EXCESSIVE INGROWTH OF COLLAGEN AND INFLAMMATION REACTIONS AROUND THE DEVICE, WHICH HAVE BEEN KNOWN AS "FOREIGN-BODY RESPONSE (FBR)"-A TYPE OF IMMUNE-MEDIATED REACTION ON FOREIGN/SYNTHETIC MATERIAL "INVADERS". EVEN FOR THE MOST SUCCESSFUL, FDA-APPROVED BIOIMPLANTS THAT HAVE BEEN USED FOR DECADES, EXCESSIVE FBR CAN BE PROVOKED IN MANY INDIVIDUALS, WHICH IS THE PRIMARY CAUSE OF THE DEVICE FAILURE BEFORE THEIR DESIRED FUNCTIONAL PERIODS. FOR SOLVING THIS COMMONLY EXISTING GRAND CHALLENGE, ALTHOUGH A SUBSTANTIAL AMOUNT OF EFFORTS HAS BEEN MADE IN THE DEVELOPMENT OF NEW BIOMATERIAL DESIGNS FOR SUPPRESSING FBR, THE RESEARCH HAS BEEN ALMOST EXCLUSIVELY FOCUSED ON INSULATING-TYPE POLYMERS/HYDROGELS. TO PROCEED TO THE NEXT HORIZON OF SOLVING THE IMMUNE-COMPATIBILITY PROBLEM FOR IMPLANTABLE ELECTRONICS USING THE MOST PROMISING MATERIAL FAMILY- ELECTRONIC POLYMERS, IT IS VITALLY IMPORTANT FOR US TO DEVELOP A SET OF INNOVATIVE MATERIAL DESIGNS FOR ELECTRONIC POLYMERS FOR CONCURRENTLY ACHIEVING SUPERIOR IMMUNE COMPATIBILITY AND HIGH ELECTRICAL PROPERTY. WE PROPOSE TO ACHIEVE THIS BY INTELLECTUALLY ADDRESSING THE EXTRAORDINARY CHALLENGE OF UNPRECEDENTEDLY INTERFACING IMMUNOLOGY WITH SEMICONDUCTOR PHYSICS AND POLYMER SCIENCES, AND EXPERIMENTALLY COMBINE THE APPROACHES OF POLYMER SYNTHESIS, MORPHOLOGICAL ENGINEERING, DEVICE FABRICATION, ELECTRICAL CHARACTERIZATIONS, IN VITRO CELL TESTS, AND IN VIVO ANIMAL TESTS. SPECIFICALLY, THE FOCUSES OF THIS RESEARCH INCLUDE FOUR ASPECTS: 1) DEVELOPING NEW DESIGNS OF SEMICONDUCTING AND CONDUCTING POLYMERS FOR ACHIEVING IMMUNOCOMPATIBLE CHEMICAL PROPERTY; 2) DEVELOPING "HYDROGEL-ARCHITECTURE" POLYMER SEMICONDUCTORS FOR REALIZING TISSUE-LEVEL ELASTIC MODULI FOR ACHIEVING IMMUNOCOMPATIBLE PHYSICAL PROPERTY; 3) IN VITRO AND IN VIVO STUDY OF THE ELICITED FBR BY THESE IMMUNOCOMPATIBLE DESIGNS OF ELECTRONIC POLYMERS; 4) COMBINING THE MATERIAL AND DEVICE DEVELOPMENTS TO REALIZE PROOF-OF-CONCEPT IMMUNOCOMPATIBLE DEVICES, INCLUDING ELECTROPHYSIOLOGICAL DEVICES, AND TRANSISTOR-BASED BIOCHEMICAL SENSORS. BASED ON THE HIGHLY IMPORTANT USES OF IMPLANTABLE ELECTRONICS, WE ENVISION THE REALIZATION OF IMMUNOCOMPATIBLE ELECTRONIC DEVICES FROM THIS RESEARCH WILL CREATE SIGNIFICANT BENEFITS AND FAR-REACHING IMPACTS TO A WIDE SPECTRUM OF BIOMEDICAL AREAS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $984.0k | 8/18/25 | ||
| Not listed | $1.4m | 9/19/22 | ||
| Not listed | $1.4m | 9/19/22 |